SCHEMBL2268533

SCHEMBL2268533

Cc1ccc(S(=O)(=O)n2ccc3cc(Br)ccc32)cc1NC1CCN(C)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.54
CYP3A4 P08684 4/20 0.49
KCNH2 Q12809 2/20 0.49
DRD2 P14416 2/20 0.49
SLC6A2 P23975 2/20 0.49
HTR2A P28223 2/20 0.49
HTR2C P28335 2/20 0.49
HTR7 P34969 2/20 0.49
HRH1 P35367 2/20 0.49
ADRA1B P35368 2/20 0.49
SLC6A3 Q01959 2/20 0.49
CYP2D6 P10635 1/20 0.49
SLC6A4 P31645 1/20 0.49
MEN1 O00255 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FABP4 P15090 2/20 0.39
FABP3 P05413 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272931 0.88 KCNH2 (0.60) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2266762 0.88 CYP3A4 (0.60) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2272938 0.88 HTR6 (0.66) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2268905 0.87 HTR6 (0.59) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2269860 0.87 CYP3A4 (0.54) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2271085 0.84 CYP3A4 (0.47) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2273734 0.83 HTR6 (0.54) HTR6CYP3A4DRD2HTR2AHTR7
SCHEMBL2268934 0.82 CYP3A4 (0.57) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2274416 0.78 CYP3A4 (0.54) HTR6CYP3A4KCNH2DRD2SLC6A2
SCHEMBL2268401 0.77 CYP3A4 (0.60) HTR6CYP3A4KCNH2DRD2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US claimed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US claimed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP claimed
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US disclosed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US disclosed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP disclosed
EP-1919896-A1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. Suven Life Sciences Limited (IN) 2008-05-14 EP disclosed
WO-2007020652-A1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LIMITED (IN) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands HTR6, HTR5A, HTR3B HTR6 1/4885CYP3A4 478/4885KCNH2 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.